People Health

Covid-19: NAFDAC Approves Pfizer-BionTech Vaccine For Emergency Use

The Director-General of NAFDAC, Prof. Mojisola Adeyeye has announced on Friday, 30th April,  the approval of Pfizer-BionTech COVID-19 vaccine for emergency use in Nigeria.

According to her, “The purpose of the press briefing is to announce that NAFDAC has just approved Pfizer-BionTech vaccines for possible use in Nigeria. They were reviewed carefully by the NAFDAC staff COVID-19 vaccine committee to make sure that the science behind the development is well understood and in accord with our world regulatory activities.”

Adeyeye made it known that, “We used different mechanisms to approve the vaccine. We used reliance, meaning that a more mature regulatory agency across the globe, we can use that as a basis for our review. We will get the assessment report, know the peculiarity there, then our COVID-19 committee will get to do their job.”

This is coming after the AstraZeneca Oxford Covid-19 vaccine arrived into the country since March, with 3.924m doses, and vaccination had since commenced.

The National Primary Health Care Development Agency NPHCDA, said over one million doses of the vaccine have so far been administered across the country in the first phase of the vaccination programme.

About the author

Esther Ifeoluwa

Add Comment

Click here to post a comment

Follow Us On

follow us, share and be part of Nigeria premier undiluted news.

Media 1

Subscribe to Our Newsletter

Don’t miss out. Get the latest

We don’t spam! Read our privacy policy for more info.


Media Show

Viral Videos